Brinzolamide Suspension/ Drops
Product Images NDC 0574-4012

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brinzolamide (NDC 0574-4012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical (Image 01)

Chemical structure diagram of brinzolamide, the active ingredient in BRINZOLAMIDE 10 mg/mL ophthalmic suspension. The structure shows its molecular arrangement including rings, nitrogen, sulfur, oxygen atoms, and side chains.*

FDA Label Image

Eye Graphic (Image 02)

FDA Label Image

Carton (Image 03)

Brinzolamide Ophthalmic Suspension USP 1% 10 mL sterile eye drops packaging label by Padagis US LLC. The label states it is for eye use only, prescription drug, and includes usage instructions, warnings, storage information at 4°C-30°C, and ingredient details with 10 mg/mL active brinzolamide and preservatives. The label also features the Padagis logo and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.